PRIMARY PERITONEAL CARCINOMA
Clinical trials for PRIMARY PERITONEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CARCINOMA trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat ovarian cancer: experimental drug combo shows promise
Disease control CompletedThis study tested an experimental drug called ZN-c3, given alone or with another drug (niraparib), in 117 people with ovarian cancer that stopped responding to platinum-based chemotherapy. The goal was to find safe doses and see if the treatment could shrink tumors or slow the di…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
New hope for Hard-to-Treat ovarian cancer: experimental combo shows promise
Disease control CompletedThis early-phase trial tested an experimental drug called SL-172154 combined with either standard chemotherapy or a targeted therapy in 86 people with ovarian cancer that stopped responding to platinum-based treatments. The main goals were to check safety and find the best dose. …
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1 • Sponsor: Shattuck Labs, Inc. • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New BRCA testing method could personalize ovarian cancer care
Knowledge-focused CompletedThis study looked at whether testing ovarian cancer tumors for BRCA gene mutations right in the doctor's office is practical and helpful. 200 patients with a specific type of ovarian cancer provided tumor samples for genetic testing. The goal was to see if this upfront testing co…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Sponsor: Cancer Trials Ireland • Aim: Knowledge-focused
Last updated May 26, 2026 05:58 UTC
-
Spit test may track hidden virus in ovarian cancer patients
Knowledge-focused CompletedThis study looked at whether saliva samples can be used to remotely monitor cytomegalovirus (CMV) infection in people receiving treatment for ovarian cancer. Researchers collected both saliva and blood samples from 49 participants to compare accuracy. The goal was to see if at-ho…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 05:45 UTC